Position in LLY
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$42,571,372
+$11,466,591 QoQ
Shares Held
35,493
+5.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.61%
of 13F equity value
Holder Rank
#594
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CX Institutional holds $115,444,232 across 15 Drug Manufacturers - General names. LLY ranks #1 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
35,493 | $42,571,372 | |
| 2 | ABBV |
AbbVie Inc.
|
78,286 | $19,699,889 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
263,596 | $15,188,401 | |
| 4 | MRK |
Merck & Co., Inc.
|
95,317 | $12,248,234 | |
| 5 | AMGN |
Amgen Inc
|
25,985 | $9,409,688 | |
| 6 | JNJ |
Johnson & Johnson
|
30,364 | $7,711,545 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
58,297 | $7,365,242 | |
| 8 | PFE |
Pfizer Inc
|
27,825 | $670,026 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,571,372 | 35,493 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $31,104,781 | 33,818 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $31,461,259 | 29,275 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $23,582,804 | 30,908 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $22,385,763 | 28,717 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $22,483,747 | 27,223 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $18,236,956 | 23,623 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $16,984,355 | 19,171 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $17,726,435 | 19,579 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $15,966,073 | 20,523 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $11,130,274 | 19,094 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $11,815,248 | 21,997 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $14,222,756 | 30,327 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $10,397,727 | 30,277 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $5,944,168 | 16,248 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,961,117 | 6,065 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,737,872 | 5,360 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,355,961 | 4,735 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,194,099 | 4,323 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $978,496 | 4,235 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $981,657 | 4,277 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,631,359 | 14,085 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $1,812,328 | 10,734 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $1,740,863 | 11,761 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,835,368 | 11,179 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,514,683 | 10,919 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||